Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP2015 vs Enbrel in Rheumatoid Arthritis (EQUIRA)
NCT02638259Phase 3Completed
- Sponsor
- Sandoz
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 16
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Sandoz. Started Feb 2015; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02638259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638259.